AC Immune (ACIU) Research & Development (2015 - 2026)
AC Immune (ACIU) recorded Research & Development of -$13.25 million in the quarter ended Jun 30, 2026, compared with -$20.32 million a year earlier.
Powered by 
Analysis
AC Immune (ACIU) Research & Development (2015 - 2026) Analysis & Trends
On a TTM basis, AC Immune's Research & Development came in at -$57.88 million as of Jun 30, 2026; for the year ended Dec 31, 2025, it came in at -$68.07 million.
- Across earlier years, Research & Development came in at -$71.12 million in the year ended Dec 31, 2024, -$60.8 million in the year ended Dec 31, 2023, -$63.25 million in the year ended Dec 31, 2022 and -$68.16 million in the year ended Dec 31, 2021.
- The figure for the quarter ended Jun 30, 2026 is the highest quarterly Research & Development since the quarter ended Sep 30, 2019.
- Per Business Quant, the preceding three quarters came in at -$15 million (quarter ended Mar 31, 2026), -$13.29 million (quarter ended Dec 31, 2025) and -$16.34 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,133.19 Bn | 1,101.77 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 616.03 Bn | 534.56 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 501.09 Bn | 474.20 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 366.82 Bn | 321.20 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 297.82 Bn | 261.81 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.33 Bn | 235.02 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 235.89 Bn | 191.29 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 190.64 Bn | 164.84 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 169.32 Bn | 115.96 Bn | 10.94 Bn | 2.81 Bn |
| 10 | AC Immune | 249.86 Mn | -188.53 Mn | - | 42.97 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 42.97 Mn |
| Mar 31, 2026 | -15.00 Mn |
| Dec 31, 2025 | 127.93 Mn |
| Sep 30, 2025 | -16.34 Mn |
| Jun 30, 2025 | 20.32 Mn |
| Mar 31, 2025 | -17.70 Mn |
| Dec 31, 2024 | 124.83 Mn |
| Sep 30, 2024 | -16.72 Mn |
| Jun 30, 2024 | 18.95 Mn |
| Mar 31, 2024 | -17.37 Mn |
| Dec 31, 2023 | 106.61 Mn |
| Sep 30, 2023 | -14.05 Mn |
| Jun 30, 2023 | 15.22 Mn |
| Mar 31, 2023 | -15.00 Mn |
| Dec 31, 2022 | 15.71 Mn |
| Sep 30, 2022 | 14.90 Mn |
| Jun 30, 2022 | 16.29 Mn |
| Mar 31, 2022 | -16.38 Mn |
| Dec 31, 2021 | 21.82 Mn |
| Sep 30, 2021 | 16.47 Mn |
API Access
AC Immune Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=ACIU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "ACIU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=ACIU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();